Samuel J. Reich - Jul 15, 2024 Form 4 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Role
CEO & EXECUTIVE CHAIRMAN, Director
Signature
/s/ Samuel J. Reich
Stock symbol
SABS
Transactions as of
Jul 15, 2024
Transactions value $
$0
Form type
4
Date filed
7/17/2024, 04:30 PM
Previous filing
Feb 23, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SABS Stock Option (right to buy) Award $0 +35.7K $0.00 35.7K Jul 15, 2024 Common Stock 35.7K $2.90 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a one-time grant to the Reporting Person as a member of the Board of Directors of the Issuer. Shares underlying the option vest 25% on July 15, 2025, and in equal monthly installments thereafter over a three-year period ending July 15, 2028.
F2 This award was made pursuant to the Issuer's 2021 Omnibus Equity Incentive Plan, as amended.